PT  - JOURNAL ARTICLE
AU  - Bauman, Julie E
AU  - Kasturi, Vijay
AU  - Birkhofer, Martin
AU  - Haddad, Robert
TI  - 673 FIERCE-HN: a multicenter, randomized, placebo-controlled, phase 3 study of ficlatuzumab + cetuximab in pts w/recurrent or metastatic (R/M) HPV-negative head and neck squamous cell carcinoma (HNSCC)
AID  - 10.1136/jitc-2023-SITC2023.0673
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A763--A763
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A763.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A763.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.